Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 706 Cr.
- Current Price ₹ 390
- High / Low ₹ 418 / 262
- Stock P/E 65.4
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 62.1 %
- ROE 76.0 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | |
|---|---|---|
| 0 | 61 | |
| 0 | 43 | |
| Operating Profit | 0 | 18 |
| OPM % | 30% | |
| 0 | 0 | |
| Interest | 0 | 3 |
| Depreciation | 0 | 1 |
| Profit before tax | 0 | 14 |
| Tax % | 25% | |
| 0 | 11 | |
| EPS in Rs | 0.00 | 8.12 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 76% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Equity Capital | 0.10 | 13 |
| Reserves | 0 | 15 |
| 0 | 27 | |
| 0 | 9 | |
| Total Liabilities | 0 | 64 |
| 0 | 13 | |
| CWIP | 0 | 6 |
| Investments | 0 | 4 |
| 0 | 41 | |
| Total Assets | 0 | 64 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| -0 | 6 | |
| 0 | -23 | |
| 0 | 17 | |
| Net Cash Flow | 0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 100 | |
| Inventory Days | 115 | |
| Days Payable | 45 | |
| Cash Conversion Cycle | 170 | |
| Working Capital Days | 101 | |
| ROCE % | 62% |
Documents
Announcements
-
Awarding of order(s)/contract(s)
20 September 2025 - Awarded L1 GeM tender GEM/2025/B/6416312 (04-Jul-2025) to supply 257,491,100 family-planning items.
-
Updates
3 September 2025 - Pre-listing shareholding pattern filed for Anondita Medicare; total equity 18,086,618 shares; promoters 61.71% on 31-08-2025.
-
Updates
1 September 2025 - Anondita Medicare files pre-listing shareholding pattern dated 01-09-2025: promoters 61.71%, public 38.29%, total 18,086,618 shares.
Annual reports
No data available.
Business Profile[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.